These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1685345)
21. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Luthman J; Bolioli B; Tsutsumi T; Verhofstad A; Jonsson G Brain Res Bull; 1987 Aug; 19(2):269-74. PubMed ID: 3664282 [TBL] [Abstract][Full Text] [Related]
22. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. Yuan H; Sarre S; Ebinger G; Michotte Y J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237 [TBL] [Abstract][Full Text] [Related]
23. Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalon. Takeuchi Y; Sawada T; Blunt S; Jenner P; Marsden CD Brain Res; 1991 Jun; 551(1-2):171-7. PubMed ID: 1680521 [TBL] [Abstract][Full Text] [Related]
24. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234 [TBL] [Abstract][Full Text] [Related]
25. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat. Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883 [TBL] [Abstract][Full Text] [Related]
27. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250 [TBL] [Abstract][Full Text] [Related]
28. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats. Jiang HK; Wang JY Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937 [TBL] [Abstract][Full Text] [Related]
29. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat. Zhang QJ; Wang S; Liu J; Ali U; Gui ZH; Wu ZH; Hui YP; Wang Y; Chen L Brain Res; 2010 Feb; 1312():127-37. PubMed ID: 19948151 [TBL] [Abstract][Full Text] [Related]
30. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment. Mura A; Feldon J; Mintz M Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571 [TBL] [Abstract][Full Text] [Related]
31. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182 [TBL] [Abstract][Full Text] [Related]
32. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Massie A; Schallier A; Mertens B; Vermoesen K; Bannai S; Sato H; Smolders I; Michotte Y Neuroreport; 2008 Oct; 19(16):1589-92. PubMed ID: 18806690 [TBL] [Abstract][Full Text] [Related]
33. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA. Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568 [TBL] [Abstract][Full Text] [Related]
34. Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons. Kamo H; Kim SU; McGeer PL; Shin DH Brain Res; 1986 Nov; 397(2):372-6. PubMed ID: 2879605 [TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Chaturvedi RK; Shukla S; Seth K; Agrawal AK Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459 [TBL] [Abstract][Full Text] [Related]
36. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749 [TBL] [Abstract][Full Text] [Related]
37. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease. Lin L; Meng T; Liu T; Zheng Z Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats. Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078 [TBL] [Abstract][Full Text] [Related]
39. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats. Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728 [TBL] [Abstract][Full Text] [Related]
40. Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat. Tashiro Y; Sugimoto T; Hattori T; Uemura Y; Nagatsu I; Kikuchi H; Mizuno N Neurosci Lett; 1989 Feb; 97(1-2):6-10. PubMed ID: 2563908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]